XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Net Sales $ 807,694 $ 888,239 $ 2,391,371 $ 2,711,635
Cost of sales 435,869 521,165 1,291,907 1,558,710
Gross profit 371,825 367,074 1,099,464 1,152,925
Selling, general and administrative expenses 108,455 116,051 336,963 431,514
Engineering, research and development expenses 80,903 66,810 234,664 209,746
Amortization of intangible assets 46,226 51,239 143,898 163,493
Goodwill, Impairment Loss 0 15,913 0 104,785
Gain on termination of alliance agreement 0 0 0 (154,754)
Operating income 136,241 117,061 383,939 398,141
Interest expense 51,666 77,820 162,726 244,874
Interest income (1,247) (2,226) (5,401) (5,854)
Other (income) expense, net (212) 10,243 17,050 13,309
Income before income tax expense (benefit) 86,034 31,224 209,564 145,812
Income tax expense (benefit) 8,190 (2,127) 18,335 2,851
Equity in net loss of affiliates 262 139 685 269
Net income $ 77,582 $ 33,212 $ 190,544 $ 142,692
Basic earnings per common share $ 0.51 $ 0.22 $ 1.26 $ 0.95
Diluted earnings per common share $ 0.51 $ 0.22 $ 1.26 $ 0.95
Weighted average shares outstanding:        
Basic 151,196 150,127 150,849 149,793
Diluted 151,924 151,229 151,820 150,816